Robafen Dm Cough Solution
NDC Package 0904-7441-20
Package Information
Robafen Dm Cough (dextromethorphan hbr, guaifenesin) solution is do not take more than directeddo not take more than 6 doses in any 24-hour periodmL = milliliteronly use the dose cup providedadults and children 12 years and over: 20 mL every 4 hourschildren under 12 years: do not use. This formulation utilizes a solution delivery system. Marketed by Major Pharmaceuticals, this product is identified by NDC 0904-7441 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1790650 - dextromethorphan HBr 10 MG / guaiFENesin 100 MG in 10 mL Oral Solution
- RxCUI: 1790650 - dextromethorphan hydrobromide 1 MG/ML / guaifenesin 10 MG/ML Oral Solution
- RxCUI: 1790650 - dextromethorphan HBr 10 MG / guaifenesin 100 MG per 10 ML Oral Solution
- RxCUI: 1790650 - dextromethorphan HBr 20 MG / guaifenesin 200 MG per 20 ML Oral Solution
- RxCUI: 1790650 - dextromethorphan HBr 5 MG / guaifenesin 50 MG per 5 ML Oral Solution
Clinical Specifications
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 0904 - Major Pharmaceuticals
- 0904-7441 - Robafen Dm Cough
- 0904-7441-20 - 1 BOTTLE, PLASTIC in 1 CARTON / 118 mL in 1 BOTTLE, PLASTIC
- 0904-7441 - Robafen Dm Cough
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0904-7441-20 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 118 ml in 1 bottle, plastic of Robafen Dm Cough, a human over the counter drug labeled by Major Pharmaceuticals. This solution is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Major Pharmaceuticals on April 05, 2024. The current certification is valid through December 31, 2027.
How is this Major Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00904744120. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.